833 related articles for article (PubMed ID: 33657296)
21. Heart as the site of first relapse in diffuse large B-cell lymphoma.
Singhal M; Raina V; Medhi K; Gupta C; Reddy RM
Indian J Cancer; 2010; 47(2):220-2. PubMed ID: 20448391
[No Abstract] [Full Text] [Related]
22. New developments in the management of diffuse large B-cell lymphoma.
Habermann TM
Hematology; 2012 Apr; 17 Suppl 1():S93-7. PubMed ID: 22507791
[TBL] [Abstract][Full Text] [Related]
23. Patients with diffuse large B cell lymphoma in partial response or stable disease after first-line R-CHOP: the prognostic value of the absolute lymphocyte count and impact of autologous stem cell transplantation.
Hung MH; Yu YB; Huang YC; Liu HT; Hong YC; Hsiao LT; Liu JH; Gau JP; Chiou TJ; Chen PM; Tzeng CH; Liu CY
Ann Hematol; 2012 Dec; 91(12):1907-15. PubMed ID: 22885989
[TBL] [Abstract][Full Text] [Related]
24. Relapsed diffuse large B-cell lymphoma--10 years later.
Jain S; Shah N; Gregory S
Clin Adv Hematol Oncol; 2011 Sep; 9(9):704-8. PubMed ID: 22402517
[No Abstract] [Full Text] [Related]
25. Diffuse large B-cell lymphoma of the breast: a distinct entity?
Bierman PJ; Villanueva ML; Armitage JO
Ann Oncol; 2008 Feb; 19(2):201-2. PubMed ID: 18187483
[No Abstract] [Full Text] [Related]
26. Effect of follicularity on autologous transplantation for large-cell non-Hodgkin's lymphoma.
Vose JM; Bierman PJ; Lynch JC; Weisenburger DD; Kessinger A; Chan WC; Greiner TC; Armitage JO
J Clin Oncol; 1998 Mar; 16(3):844-9. PubMed ID: 9508164
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of high-dose cyclophosphamide, etoposide and ranimustine regimen followed by autologous peripheral blood stem cell transplant for patients with diffuse large B-cell lymphoma.
Kobayashi Y; Hatta Y; Sugitani M; Hojo A; Nakagawa M; Kusuda M; Uchino Y; Takahashi H; Kiso S; Hirabayashi Y; Yagi M; Kodaira H; Kurita D; Miura K; Iriyama N; Kobayashi S; Kura Y; Horikoshi A; Sawada U; Takeuchi J; Takei M
Leuk Lymphoma; 2014 Nov; 55(11):2514-9. PubMed ID: 24491027
[TBL] [Abstract][Full Text] [Related]
28. Disease characteristics of diffuse large B-cell lymphoma predicting relapse and survival after autologous stem cell transplantation: A single institution experience.
Gaut D; Romero T; Oveisi D; Howell G; Schiller G
Hematol Oncol; 2020 Feb; 38(1):38-50. PubMed ID: 31674036
[TBL] [Abstract][Full Text] [Related]
29. Absolute monocyte count is a prognostic indicator in a patient with diffuse large B-cell lymphoma after autologous peripheral blood stem cell transplant.
Mo H; Shi Y; Han X; Zhou S; He X; Liu P; Yang J; Zhang C; Yang S; Qin Y; Gui L; Shi Y; Yao J; Zhao L; Zhang S
Leuk Lymphoma; 2015 Feb; 56(2):515-7. PubMed ID: 24844360
[No Abstract] [Full Text] [Related]
30. A multicentre, phase II trial of ofatumumab monotherapy in relapsed/progressive diffuse large B-cell lymphoma.
Coiffier B; Radford J; Bosly A; Martinelli G; Verhoef G; Barca G; Davies A; Decaudin D; Gallop-Evans E; Padmanabhan-Iyer S; Van Eygen K; Wu KL; Gupta IV; Lin TS; Goldstein N; Jewell RC; Winter P; Lisby S;
Br J Haematol; 2013 Nov; 163(3):334-42. PubMed ID: 24032456
[TBL] [Abstract][Full Text] [Related]
31. CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 23-2015. A 51-Year-Old Woman with Headache, Cognitive Impairment, and Weakness.
Batchelor TT; Chen YB; Rapalino O; Cobos I
N Engl J Med; 2015 Jul; 373(4):367-77. PubMed ID: 26200983
[No Abstract] [Full Text] [Related]
32. Role of frontline autologous stem cell transplantation in young, high-risk diffuse large B-cell lymphoma patients.
Yoon JH; Kim JW; Jeon YW; Lee SE; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Park CW; Cho SG
Korean J Intern Med; 2015 May; 30(3):362-71. PubMed ID: 25995667
[TBL] [Abstract][Full Text] [Related]
33. [Recent therapeutic progress in non-Hodgkin lymphoma: focusing on diffuse large B-cell lymphoma and follicular lymphoma].
Ogura M
Rinsho Ketsueki; 2008 Oct; 49(10):1434-50. PubMed ID: 18833928
[No Abstract] [Full Text] [Related]
34. Diffuse large B-cell lymphoma in a patient with hyper-IgE syndrome: Successful treatment with risk-adapted rituximab-based immunochemotherapy.
Belada D; Smolej L; Stepánková P; Králícková P; Freiberger T
Leuk Res; 2010 Sep; 34(9):e232-4. PubMed ID: 20226523
[No Abstract] [Full Text] [Related]
35. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
[TBL] [Abstract][Full Text] [Related]
36. [Standard therapy and research questions in diffuse large B-cell lymphoma].
Yamamoto K
Rinsho Ketsueki; 2012 Oct; 53(10):1634-48. PubMed ID: 23037736
[No Abstract] [Full Text] [Related]
37. Prolonged hospitalization, primary refractory disease, performance status and age are prognostic factors for survival in patients with diffuse large B-cell lymphoma and transformed indolent lymphoma undergoing autologous stem cell transplantation.
Arboe B; Halgren Olsen M; Duun-Henriksen AK; Gørløv JS; Nielsen KF; Thomsen RH; Madsen C; Nielsen SR; Dalton SO; Brown PN
Leuk Lymphoma; 2018 May; 59(5):1153-1162. PubMed ID: 28868963
[TBL] [Abstract][Full Text] [Related]
38. Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Schuster SJ; Bishop MR; Tam CS; Waller EK; Borchmann P; McGuirk JP; Jäger U; Jaglowski S; Andreadis C; Westin JR; Fleury I; Bachanova V; Foley SR; Ho PJ; Mielke S; Magenau JM; Holte H; Pantano S; Pacaud LB; Awasthi R; Chu J; Anak Ö; Salles G; Maziarz RT;
N Engl J Med; 2019 Jan; 380(1):45-56. PubMed ID: 30501490
[TBL] [Abstract][Full Text] [Related]
39. Fourth complete remission with immunosuppression withdrawal and irinotecan after both autologous and allogeneic transplants for diffuse large B cell lymphoma.
Gupta NK; Barker JN; Young JW; Noy A
Leuk Lymphoma; 2009 Dec; 50(12):2075-7. PubMed ID: 19637088
[No Abstract] [Full Text] [Related]
40. Primary diffuse large B-cell lymphoma of the palpebral conjunctiva.
Kim NJ; Khwarg SI
Can J Ophthalmol; 2007 Aug; 42(4):630-1. PubMed ID: 17641717
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]